Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Influenza A Virus Matrix Protein 1 Produkte

(Influenza A Virus Matrix Protein 1 (M1))

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Ausgewählte Influenza A Virus Matrix Protein 1 Kategorien

Influenza A Virus Matrix Protein 1 Antikörper

High quality antibodies with extensive validation data.

Influenza A Virus Matrix Protein 1 Proteine

Proteins for various applications incl. WB, ELISA, IF etc.

Empfohlene Influenza A Virus Matrix Protein 1 Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Influenza A Virus
Applikation ELISA
Validierungen
  • (1)
Kat. Nr. ABIN5707180
Menge 0.1 mg
Datenblatt Datenblatt
Reaktivität Influenza A Virus
Applikation ELISA
Validierungen
  • (1)
Kat. Nr. ABIN5707179
Menge 1 mL
Datenblatt Datenblatt
Reaktivität Influenza A Virus
Applikation WB, IF
Validierungen
  • (1)
Kat. Nr. ABIN4369561
Menge 1 mg
Datenblatt Datenblatt

Empfohlene Influenza A Virus Matrix Protein 1 Proteine

Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Influenza A Virus H5N1
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN1604957
Menge 100 μg
Datenblatt Datenblatt
Reaktivität Influenza A Virus H7N9
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN1605454
Menge 100 μg
Datenblatt Datenblatt
Reaktivität Influenza A Virus H1N1
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN1605276
Menge 100 μg
Datenblatt Datenblatt

Neueste Publikationen zu unseren Influenza A Virus Matrix Protein 1 Produkten

Deo, Kato, Park: "Chimeric virus-like particles made using GAG and M1 capsid proteins providing dual drug delivery and vaccination platform." in: Molecular pharmaceutics, Vol. 12, Issue 3, pp. 839-45, (2015) (PubMed).

Das, Watanabe, Hatta, Noda, Neumann, Ozawa, Kawaoka: "The highly conserved arginine residues at positions 76 through 78 of influenza A virus matrix protein M1 play an important role in viral replication by affecting the intracellular localization of M1." in: Journal of virology, Vol. 86, Issue 3, pp. 1522-30, (2012) (PubMed).

Doucet, Forget, Grange, Rouxel, Arbour, von Messling, Lapointe: "Endogenously expressed matrix protein M1 and nucleoprotein of influenza A are efficiently presented by class I and class II major histocompatibility complexes." in: The Journal of general virology, Vol. 92, Issue Pt 5, pp. 1162-71, (2011) (PubMed).

Liu, Massare, Barnard, Kort, Nathan, Wang, Smith: "Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV." in: Vaccine, Vol. 29, Issue 38, pp. 6606-13, (2011) (PubMed).

Viemann, Schmolke, Lueken, Boergeling, Friesenhagen, Wittkowski, Ludwig, Roth: "H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 186, Issue 1, pp. 164-73, (2010) (PubMed).

Wang, Harmon, Jin, Francis, Christopher-Hennings, Nelson, Montelaro, Li: "The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles." in: Journal of virology, Vol. 84, Issue 9, pp. 4673-81, (2010) (PubMed).

Luig, Köther, Dudek, Gaestel, Hiscott, Wixler, Ludwig: "MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 24, Issue 10, pp. 4068-77, (2010) (PubMed).

Eierhoff, Hrincius, Rescher, Ludwig, Ehrhardt: "The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells." in: PLoS pathogens, Vol. 6, Issue 9, pp. e1001099, (2010) (PubMed).

Kang, Yoo, Lipatov, Song, Davis, Quan, Chen, Donis, Compans: "Induction of long-term protective immune responses by influenza H5N1 virus-like particles." in: PLoS ONE, Vol. 4, Issue 3, pp. e4667, (2009) (PubMed).

Kirkeby, Martel, Aasted: "Infection with human H1N1 influenza virus affects the expression of sialic acids of metaplastic mucous cells in the ferret airways." in: Virus research, Vol. 144, Issue 1-2, pp. 225-32, (2009) (PubMed).

Sie sind hier:
Kundenservice